106 related articles for article (PubMed ID: 37179748)
1. Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model.
Jeong AY; Lee P; Lee MS; Kim DJ
Immune Netw; 2023 Apr; 23(2):e19. PubMed ID: 37179748
[TBL] [Abstract][Full Text] [Related]
2. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
[TBL] [Abstract][Full Text] [Related]
3. The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
Soni MK; Migliori E; Fu J; Assal A; Chan HT; Pan J; Khatiwada P; Ciubotariu R; May MS; Pereira MR; De Giorgi V; Sykes M; Mapara MY; Muranski PJ
Front Immunol; 2023; 14():1212203. PubMed ID: 37901229
[TBL] [Abstract][Full Text] [Related]
4. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
[TBL] [Abstract][Full Text] [Related]
6. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
7. Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel.
Ng KW; Faulkner N; Wrobel AG; Gamblin SJ; Kassiotis G
Semin Immunol; 2021 Jun; 55():101507. PubMed ID: 34716096
[TBL] [Abstract][Full Text] [Related]
8. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT
Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974
[TBL] [Abstract][Full Text] [Related]
9. The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
Soni M; Migliori E; Fu J; Assal A; Chan HT; Pan J; Khatiwada P; Ciubotariu R; May MS; Pereira M; De Giorgi V; Sykes M; Mapara MY; Muranski P
bioRxiv; 2023 Jan; ():. PubMed ID: 36711835
[TBL] [Abstract][Full Text] [Related]
10. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
11. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2020; 11():607918. PubMed ID: 33424856
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2.
Denninger V; Xu CK; Meisl G; Morgunov AS; Fiedler S; Ilsley A; Emmenegger M; Malik AY; Piziorska MA; Schneider MM; Devenish SRA; Kosmoliaptsis V; Aguzzi A; Fiegler H; Knowles TPJ
ACS Infect Dis; 2022 Apr; 8(4):790-799. PubMed ID: 35352558
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities.
Imai K; Matsuoka M; Tabata S; Kitagawa Y; Nagura-Ikeda M; Kubota K; Fukada A; Takada T; Sato M; Noguchi S; Takeuchi S; Arakawa N; Miyoshi K; Saito Y; Maeda T
Int J Infect Dis; 2021 Oct; 111():68-75. PubMed ID: 34407480
[TBL] [Abstract][Full Text] [Related]
15. Broad Cross-reactive IgA and IgG Against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection.
Wang J; Young BE; Li D; Seppo AE; Zhou Q; Wiltse A; Nowak-Wegrzyn A; Murphy K; Widrick K; Diaz N; Cruz-Vasquez J; Järvinen KM; Zand MS
medRxiv; 2022 Mar; ():. PubMed ID: 35313594
[TBL] [Abstract][Full Text] [Related]
16. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
[TBL] [Abstract][Full Text] [Related]
17. An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines.
Al-Sheboul SA; Brown B; Shboul Y; Fricke I; Imarogbe C; Alzoubi KH
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679897
[TBL] [Abstract][Full Text] [Related]
18. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
Front Immunol; 2022; 13():836449. PubMed ID: 35401521
[TBL] [Abstract][Full Text] [Related]
19. Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection.
Wang J; Young BE; Li D; Seppo A; Zhou Q; Wiltse A; Nowak-Wegrzyn A; Murphy K; Widrick K; Diaz N; Cruz-Vasquez J; M Järvinen K; Zand MS
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746588
[TBL] [Abstract][Full Text] [Related]
20. Adaptive immunity to human coronaviruses is widespread but low in magnitude.
Tan HX; Lee WS; Wragg KM; Nelson C; Esterbauer R; Kelly HG; Amarasena T; Jones R; Starkey G; Wang BZ; Yoshino O; Tiang T; Grayson ML; Opdam H; D'Costa R; Vago A; ; Mackay LK; Gordon CL; Wheatley AK; Kent SJ; Juno JA
Clin Transl Immunology; 2021; 10(3):e1264. PubMed ID: 33747512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
